Stay updated on Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.

Latest updates to the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page
- Check3 days agoChange DetectedNew user-help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment header formatting was standardized. The page revision tag was updated from v3.5.5 to v3.6.0, reflecting an updated version of the page.SummaryDifference0.5%

- Check10 days agoChange DetectedThe revision indicator on the page was bumped from v3.5.4 to v3.5.5, reflecting a small update to the page’s backend or content. No substantive information or functionality related to the study is affected.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, representing an incremental update to the page's documentation/configuration. No study content, eligibility criteria, or results are affected by this change.SummaryDifference0.1%

- Check53 days agoChange DetectedUpdated the ClinicalTrials.gov page revision/version indicator from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded Gorlin syndrome as a related term and included the Genetic and Rare Diseases Information Center as a new resources link.SummaryDifference0.2%

Stay in the know with updates to Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vismodegib in Basal Cell Nevus Syndrome Clinical Trial page.